Karen Vernon

648 total citations
19 papers, 505 citations indexed

About

Karen Vernon is a scholar working on Infectious Diseases, General Health Professions and Epidemiology. According to data from OpenAlex, Karen Vernon has authored 19 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in General Health Professions and 10 papers in Epidemiology. Recurrent topics in Karen Vernon's work include HIV/AIDS Research and Interventions (10 papers), HIV, Drug Use, Sexual Risk (10 papers) and Adolescent Sexual and Reproductive Health (6 papers). Karen Vernon is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV, Drug Use, Sexual Risk (10 papers) and Adolescent Sexual and Reproductive Health (6 papers). Karen Vernon collaborates with scholars based in United States, United Kingdom and Germany. Karen Vernon's co-authors include Kelly R. Knight, Ariane van der Straten, Nancy Padian, Stephen F. Morin, Martin Marziniak, Sven G. Meuth, Uta Meyding‐Lamadé, Giampaolo Brichetto, Peter Feys and Kimberly A. Koester and has published in prestigious journals such as Journal of Periodontology, JAIDS Journal of Acquired Immune Deficiency Syndromes and AIDS and Behavior.

In The Last Decade

Karen Vernon

17 papers receiving 489 citations

Peers

Countries citing papers authored by Karen Vernon

Since Specialization

Citations

This map shows the geographic impact of Karen Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Vernon more than expected).

Fields of papers citing papers by Karen Vernon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Vernon. The network helps show where Karen Vernon may publish in the future.

Co-authorship network of co-authors of Karen Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Vernon. A scholar is included among the top collaborators of Karen Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Vernon. Karen Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Modeling the Multiple Sclerosis Specialist Nurse Workforce by Determination of Optimum Caseloads in the United Kingdom 2020 ·International Journal of MS Care ·Geoffrey Punshon, (unknown), (unknown), (unknown), Karen Vernon, (unknown), Alison Leary	4
2	The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review 2018 ·JMIR Rehabilitation and Assistive Technologies ·Martin Marziniak, Giampaolo Brichetto, Peter Feys, Uta Meyding‐Lamadé, Karen Vernon, Sven G. Meuth	90
3	Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series. 2018 ·PubMed ·(unknown), Karen Vernon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura A. Johnson	12
4	Variations in multiple sclerosis practice within Europe – Is it time for a new treatment guideline? 2016 ·Multiple Sclerosis and Related Disorders ·Martin Marziniak, Karima Ghorab, Wojciech Kozubski, Claudia Pfleger, Lívia Sousa, Karen Vernon, Mauro Zaffaroni, Sven G. Meuth	20
5	An exciting era of treatments for relapsing-remitting multiple sclerosis 2014 ·British Journal of Neuroscience Nursing ·(unknown), Karen Vernon, Richard Warner	0
6	Implementation of HIV Prevention Interventions with People Living with HIV/AIDS in Clinical Settings: Challenges and Lessons Learned 2007 ·AIDS and Behavior ·Kimberly A. Koester, André Maiorana, Karen Vernon, Janet J. Myers, Carol Dawson Rose, Stephen F. Morin	30
7	What's Community Got to Do With It? Implementation Models of Syringe Exchange Programs 2005 ·AIDS Education and Prevention ·(unknown), (unknown), Karen Vernon, Nina Mulia, (unknown), Courtney McKnight, Don C. Des Jarlais, Brian R. Edlin	34
8	HIV surveillance in theory and practice: Assessing the acceptability of California's non-name HIV surveillance regulations 2005 ·Health Policy ·Kimberly A. Koester, André Maiorana, Karen Vernon, Edwin D. Charlebois, (unknown), Tim Lane, Stephen F. Morin	1
9	Missed Opportunities: Prevention With HIV-Infected Patients in Clinical Care Settings 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Stephen F. Morin, Kimberly A. Koester, Wayne T. Steward, André Maiorana, (unknown), Janet J. Myers, Karen Vernon, Margaret A. Chesney	73
10	Why HIV Infections Have Increased Among Men Who Have Sex with Men and What to Do About It: Findings from California Focus Groups 2003 ·AIDS and Behavior ·Stephen F. Morin, Karen Vernon, John K. Harcourt, Wayne T. Steward, Jonathan E. Volk, (unknown), Torsten B. Neilands, (unknown), Thomas J. Coates	38
11	Attitudes to long-term care in multiple sclerosis 2003 ·Nursing Standard ·(unknown), (unknown), Caroline T. Brown, (unknown), (unknown), (unknown), (unknown), Anne M. McCaffrey, (unknown), (unknown), Benedetta Rossi, Andrew Russell, Karen Vernon	1
12	Specialist nurse network improves MS practice. 2002 ·PubMed ·(unknown), (unknown), (unknown), Karen Vernon	4
13	The HIV care continuum in publicly funded clinics 2002 ·Public Health Reports ·T. Anne Richards, Karen Vernon, Herminia Palacio, James G. Kahn, Stephen F. Morin	7
14	“I don't know when it might pop up” 2001 ·Journal of Substance Abuse ·Karen Vernon, Nina Mulia, (unknown), Kelly R. Knight, Thomas Reiß	8
15	Drug users talk about HIV testing: Motivating and deterring factors 2001 ·AIDS Care ·(unknown), Kelly R. Knight, (unknown), Karen Vernon, Nina Mulia, (unknown), Allison J. Carroll, Chi B. Vu	46
16	Voices from the field: providers discuss HIV counseling and testing programs for drug users. 2000 ·PubMed ·(unknown), Nina Mulia, Karen Vernon, Kelly R. Knight, (unknown), (unknown)	8
17	This Is My Story: A Descriptive Analysis of a Peer Education HIV/STD Risk Reduction Program for Women Living in Housing Developments 1999 ·AIDS Education and Prevention ·(unknown), K.R. Knight, Karen Vernon, (unknown), (unknown), (unknown), Laine Thomas, Sarah Porter	12
18	A Method for Determining Patient Oral Care Skills: The University of Mississippi Oral Hygiene Index 1998 ·Journal of Periodontology ·(unknown), (unknown), Francis G. Serio, Meenakshi Devidas, (unknown), Karen Vernon	16
19	Managing HIV among serodiscordant heterosexual couples: Serostatus, stigma and sex 1998 ·AIDS Care ·Ariane van der Straten, Karen Vernon, Kelly R. Knight, (unknown), Nancy Padian	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact